Rising Number of Latinos Diagnosed With Alzheimer’s Disease
By the year 2060, the number of Latinos in the United States with Alzheimer’s disease is expected to rise by more than 8 times. Alzheimer’s is increasingly common in the US, but Latinos represent the fastest growing minority, reported Kaiser Health News. This population is at least 50% more likely to develop the disease than whites, and they are more likely to have a family member care for someone with Alzheimer’s rather than place the person in a nursing home. But using formal care services is now becoming more common among Latinos.
Government Sues UnitedHealth Over Medicare Scheme
A lawsuit against UnitedHealth Group alleges that the insurer overcharged Medicare hundreds of millions of dollars. According to Reuters, the lawsuit, which was filed in 2011 but was just unsealed on February 16, claims the insurer depicted Medicare members as being sicker than they were. The Department of Justice has joined the lawsuit against UnitedHealth, as well as one against WellMed Medical Management, which UnitedHealth bought in 2011.
Evidence Shows Wearable Devices Don’t Result in Weight Loss
Wearable technology like Fitbit and Apple Watch, may be encouraging people to be more active, but they aren’t resulting in people losing more weight. In a column for The New York Times’ "The Upshot," Aaron E. Carroll, MD, MS, lays out the evidence from past trials that show people using wearable devices lose less weight than people not using these devices. These devices are good for improving activity over time, but not for losing weight.
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More
Consumers should not eat precut cantaloupe if they do not know the source, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows; the White House and the Department of Education urged schools to take proactive steps to prevent youth drug use; a study published this week found a high prevalence of arrhythmia in patients with long COVID.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available
November 30th 2023Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.
Read More